This commentary focuses on the implications of herpes zoster prevalence in kidney transplant recipients.
Review of data regarding herpes zoster incidence in kidney transplant patients.
Analysis of clinical implications of viral infections in immunocompromised individuals.
Highlights the increased vulnerability of kidney transplant patients to herpes zoster.
Emphasizes the need for awareness and management strategies in this population.
Abstract
The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.